T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Teradyne
TER
$65.4B
| $55.4M | 0.01% |
2,939,722
-306,357
| -9% | -$5.87M |
|
802
RLI Corp
RLI
$5.81B
| $55.3M | 0.01% |
2,109,680
+5,504
| +0.3% | +$136K |
|
|
ASEI
803
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $55.3M | 0.01% |
1,131,383
-11,400
| -1% | -$575K |
|
804
PACCAR
PCAR
$68.2B
| $55.3M | 0.01% |
1,312,601
+175,178
| +15% | +$7.44M |
|
|
CIR
805
DELISTED
CIRCOR International, Inc
CIR
| $54.9M | 0.01% |
1,002,900
+32,580
| +3% | +$1.73M |
|
|
SWC
806
DELISTED
Stillwater Mining Co
SWC
| $54.8M | 0.01% |
4,244,131
+114,740
| +3% | +$1.59M |
|
807
Aaon
AAON
$7.43B
| $54.5M | 0.01% |
3,335,496
+62,655
| +2% | +$946K |
|
808
Aflac
AFL
$60.6B
| $54.5M | 0.01% |
1,702,826
+35,980
| +2% | +$1.1M |
|
809
J.M. Smucker
SJM
$12.9B
| $54.4M | 0.01% |
470,374
-491,464
| -51% | -$53.9M |
|
|
HTS
810
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $54.3M | 0.01% |
2,991,410
+412,490
| +16% | +$7.51M |
|
811
Woodward
WWD
$21.2B
| $54.1M | 0.01% |
1,061,390
-467,653
| -31% | -$22.3M |
|
|
B
812
Barrick Mining
B
$67B
| $54.1M | 0.01% |
4,934,010
+4,901,410
| +15,035% | +$58M |
|
813
FTI Consulting
FCN
$4.17B
| $53.8M | 0.01% |
1,436,745
-8,000
| -0.6% | -$302K |
|
814
Enpro
NPO
$7.2B
| $53.8M | 0.01% |
815,488
-1,092,034
| -57% | -$69.9M |
|
815
Affiliated Managers Group
AMG
$9.58B
| $53.4M | 0.01% |
248,745
+112,146
| +82% | +$23.7M |
|
816
CALL
American Airlines Group
AAL
$9.94B
| $53.2M | 0.01% |
1,008,000
+980,500
| +3,565% | +$49.8M |
|
|
KAMN
817
DELISTED
Kaman Corp
KAMN
| $52.8M | 0.01% |
1,244,294
-507,248
| -29% | -$20.3M |
|
818
Steven Madden
SHOO
$3.46B
| $52.6M | 0.01% |
2,074,503
+605,652
| +41% | +$14.2M |
|
|
HI
819
DELISTED
Hillenbrand
HI
| $52.5M | 0.01% |
1,701,430
+209,260
| +14% | +$6.57M |
|
820
Badger Meter
BMI
$3.82B
| $52.5M | 0.01% |
1,751,820
+57,248
| +3% | +$1.67M |
|
|
RICE
821
DELISTED
Rice Energy Inc.
RICE
| $52.5M | 0.01% |
2,411,250
+323,556
| +15% | +$6.14M |
|
|
ARMH
822
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $52.4M | 0.01% |
1,063,350
-1,238,900
| -54% | -$61.6M |
|
|
SNV
823
DELISTED
Synovus
SNV
| $52.4M | 0.01% |
1,869,383
+14,956
| +0.8% | +$406K |
|
|
KTWO
824
DELISTED
K2M Group Holdings, Inc
KTWO
| $52.3M | 0.01% |
2,371,410
+1,237,190
| +109% | +$25.3M |
|
825
Murphy USA
MUSA
$10.2B
| $52.2M | 0.01% |
721,423
+233,140
| +48% | +$16.4M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.